ɔːɹblˈɪviən sˈoʊld wˈɛl ɪn jˈʊɹɹəp ænd ðə juːnˈaɪɾᵻd stˈeɪts, ɹˈiːtʃɪŋ nˈʌmbɚ nˈaɪntiːn ɔnðə jˌuːkˈeɪ ˈælbəmz tʃˈɑːɹt ænd nˈʌmbɚ wˈʌnhˈʌndɹɪd sˈɛvənti fˈoːɹ ɔnðə jˌuːˈɛs bˈɪlboːɹd tˈuːhˈʌndɹɪd, wˌaɪl ɪts lˈiːd sˈɪŋɡəl "tˈɑːksɪdʒˌiːn" bɪkˌeɪm ðə hˈaɪɪsttʃˈɑːɹɾɪŋ sˈɪŋɡəl baɪ ðɪ ˈɔːɹb, ɹˈiːtʃɪŋ nˈʌmbɚ fˈoːɹ ɪnðə jˌuːkˈeɪ.
Orblivion sold well in Europe and the United States, reaching number nineteen on the UK Albums Chart and number 174 on the US Billboard 200, while its lead single "Toxygene" became the highest-charting single by The Orb, reaching number four in the UK.